BRANDL TALOS advises sellers on the sale of a 60% stake in SICO Technology to Wietersdorfer Group

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Daniel Habich

The existing shareholders of SICO Technology, a global leader in the processing of silicon, quartz, and ceramics for the semiconductor industry, have successfully sold a 60% stake to the Wietersdorfer Group, a leading building materials producer.

The transaction marks a significant milestone in SICO’s journey since its foundation in 1981. SICO has consistently evolved over the years to become a recognized specialist within its field, and its partnership with Wietersdorfer will further strengthen its standing in the global market.

AWS Mittelstandsfonds, which has supported SICO Technology as a shareholder since 2015, successfully exited its final investment with this sale whereas Walter Nadrag remains invested with a 40% stake.

The BRANDL TALOS deal team advising the Sellers was led by Roman Rericha and Stephan Strass and further supported by Daniel Habich. Walter Nadrag was, in addition, advised by Joachim Bucher of Bucher & Partner.

Silverpeak acted as the exclusive financial advisor to Sico Technology. The Silverpeak team was led by Oliver Markl, Pietro Strada, Anne Belcredi and Fabian Probst.

The team
Roman Rericha
Partner / Fund Formation, Venture Capital & Start Ups, Corporate Law & Transactions
Roman represents clients in complex cross-border M&A and private equity transactions. Austrian and international venture capital funds regularly turn to him for assisting with investments in Austria. His expert advice also guides start-ups through large-scale financing rounds.

University of Vienna, Faculty of Law (Mag. iur. 2005),
Faculty of Business, Economics and Statistics, (Mag. rer.soc.oec. 2007)
Stephan Strass
Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience
Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)
Daniel Habich
Associate / Venture Capital & Start Ups, Corporate Law & Transactions
Daniel is part of our team since 2022, at that time as research assistant. Since 2023 he has started working for us as associate.

Wirtschaftsuniversität Wien, Business Law (Master of Laws 2022)
Wirtschaftsuniversität Wien, Business Law (Bachelor of Laws 2020)